Strong Clinical Network

Scientific Advisory Board with Internationally Renowned Experts

The Scientific Advisory Board meets  several  times  per  year  and  chair roundtables with further key opinion leaders in the field to advise the company on important trends and issues in clinical microbiology as well as novel product concepts addressing high medical need questions in the diagnosis of severe infections in hospitalized patients.

Scientific Advisory Board in Europe

Reno Frei, MD, Head of Clinical Microbiology

Reno Frei, MD, was Head of the Division of Clinical Microbiology, University Hospital Basel, Switzerland,  for  more  than  25  years.  His  research  focuses  on  antibiotic  resistance, microbiological diagnostics, and healthcare-associated infections including prosthetic device infections and sepsis. He has published 250 peer-reviewed articles and book chapters. Dr. Frei received his medical degree from the University of Basel Faculty of Medicine in 1980. He completed his training in infectious diseases and laboratory medicine with a research fellowship at the University of Iowa College of Medicine, Iowa City, USA.

Dr. Laurent Poirel, Associate Professor of Microbiology

Dr. Laurent Poirel works as Associate Professor in the Microbiology Unit, Department of Medicine of the Faculty of Science at the University of Fribourg, Switzerland (director: Prof. Patrice Nordmann). He has a long-standing scientific career at the French National Institute of Health and Medical Research (INSERM) in Paris / France. His research area is genetics, biochemistry and epidemiology of antibiotic resistance determinants with focus on ß-lactam, aminoglycoside, carbapenem and quinolone resistances. In addition, he and his team have jointly developed a variety of rapid diagnostic tests for detection of extended-spectrum ß-lactamases and carbapenemases. Dr. Poirel has co-authored more than 430 publications in peer-reviewed journals and is frequently invited speaker at international science and industry conferences including among others the International Conference on Antimicrobial Agents and Chemotherapy (ICAAC) and the European Congress for Clinical Microbiology and Infectious Diseases (ECCMID). In addition, he is a member of both, the ICAAC Program Committee and the ESCMID Executive Subcommittee and serves as editor or member on editorial board of various international journals.

Jean-Louis Vincent, MD, PhD, Professor of Intensive Care

Jean-Louis Vincent, MD, PhD, is Professor of Intensive Care at the University of Brussels and Intensivist in the Department of Intensive Care at the Erasme University Hospital in Brussels, Belgium. He has published more than 900 peer-reviewed articles, some 400 book chapters and review articles, 950 original abstracts, and has edited 101 books. Among others, he is the Editor-In-Chief of Critical Care, Current Opinion in Critical Care and ICU Management and a member of the editorial boards of about 30 other journals. Jean-Louis Vincent received numerous awards, including the prestigious Prix Scientifique Joseph Maisin-Sciences biomédicales cliniques.Prof. Vincent is a Past-President of the European Society of Intensive Care Medicine and presently President of the World Federation of Societies of Intensive and Critical Care Medicine.

Scientific Advisory Board in the US

Pharm. D. Debra A. Goff, FCCP, Infectious Diseases Specialist

Debra Goff is an Infectious Disease Specialist and founding member of the Antimicrobial Stewardship Program at The Ohio State University Wexner Medical Center (OSUWMC) in Columbus Ohio. She is the past-Director of the Infectious Diseases Residency program at OSUWMC. She is an Associate Professor at the College of Pharmacy working with the One Health Antibiotic Stewardship team at OSU. Dr. Goff received her Bachelor of Pharmacy and Doctor of Pharmacy degrees from the University of Illinois at Chicago, where she also completed her residency.
Dr. Goff is a 2016 TEDx Columbus speaker on antibiotics “just in case” there’s infection. She is the international advisor to the Federation of Infectious Diseases Society of South Africa (FIDSSA) mentoring South African pharmacists. She received the 2016 OSU Emerging International Outreach and Engagement Award for her work in South Africa. She is the 2017 American College of Clinical Pharmacy (ACCP) recipient of the Global Health Award. She serves as a faculty mentor to young African leaders as part of the Mandela Washington Fellowship Program. Dr. Goff is a faculty member of the World Health Organization (WHO) Pathogens Priority List Working Group.
Her interests include antimicrobial resistance, the application of rapid diagnostic tests with stewardship interventions, use of Twitter to increase global engagement and cross collaboration with surgeons, oncologists, veterinarians, and patient advocate organizations in antibiotic stewardship. She lectures nationally and internationally as an antimicrobial stewardship advocate.

M.D. Donna Mildvan, Clinical Professor of Medicine

Donna Mildvan, M.D., FACP, FIDSA is a clinical Professor of Medicine at Ichan School of Medicine at Mount Sinai in New York, NY. Prior to her current position, she was Chief, Infectious Diseases and AIDS Divisions and Director of AIDS Research at Mount Sinai Beth Israel, and Co-Principal/Principal Investigator, AIDS Clinical Trials Group. Dr. Mildvan received her medical degree from Johns Hopkins University School of Medicine. She is a Diplomate of the American  Board of Internal Medicine and a Diplomate of the American Board of Infectious Diseases. She is widely recognized for her significant contributions to science, including early descriptions of AIDS and its complications, and the development of an algorithm for biomarker validation which has been broadly recognized and applied across clinical disciplines. She is the recipient of several awards of excellence is medical research. Dr. Mildvan is Chair of numerous study protocols and member of NIH review committees, Pneumonia Technical Expert Panel, and she has served as consultant to the CDC and FDA. Dr. Mildvan has co-authored more than 200 peer reviewed publications. She has had a longstanding interest in community acquired pneumonia and studies addressing antimicrobial prescribing and its impact on the emergence of drug resistance. Her research focus includes innovative trial design and drug development, biomarker research, and championing minority representation in clinical trials.

Dr. Melissa Miller, PhD, D(ABMM), Professor of Pathology and Laboratory Medicine

Dr. Melissa Miller, PhD, D(ABMM), is a Professor of Pathology and Laboratory Medicine at the University of North Carolina at Chapel Hill School of Medicine. She is also the Director of the Clinical Molecular Microbiology Laboratory and Associate Director of the Microbiology-Immunology Laboratory for UNC Health Care. She received her Ph.D. in Molecular Biology from Princeton University and completed the Medical and Public Health Microbiology Fellowship at UNC. She is the current chair of the ASM Committee on Laboratory Practices, the co-chair of the Pan American Society for Clinical Virology Professional Practices Committee, and a Fellow of the American Academy of Microbiology.  Dr. Miller has broad research interests spanning from the epidemiology of drug resistant organisms to accurate and cost-effective molecular detection of viral infections. She is particularly interested in the assessment of patient and healthcare outcomes associated with the implementation of new molecular technologies. 

Ph. D. Frederick S. Nolte Professor and Vice Chair for Laboratory Medicine

Dr. Nolte is currently Professor and Vice Chair for Laboratory Medicine in the Department of Pathology and Laboratory Medicine, and Medical Director of Clinical Laboratories, and Molecular Pathology at the Medical University of South Carolina. He is a Diplomate of the American Board of Medical Microbiology and a Fellow of the American Academy of Microbiology.
Dr. Nolte completed his B.S. degree in biology at the University of Cincinnati and his Ph.D. in medical microbiology at the Ohio State University. Dr. Nolte completed a postdoctoral fellowship in public health and medical laboratory microbiology at the University of Rochester. Prior to coming to MUSC in 2007 he spent 18 years at Emory University School of Medicine where he was a Professor of Pathology and Laboratory Medicine and Director of the Clinical Microbiology, Molecular Diagnostic, and Serology Laboratories, Emory Medical Laboratories.
He is active in and held positions of responsibility in the American Society for Microbiology, Association for Molecular Pathology, Clinical and Laboratory Standards Institute, Infectious Diseases Society of America, American Society for Clinical Pathology, American Association for Clinical Chemistry, and College of American Pathologists.  He has authored numerous book chapters, practice guidelines, and more than 100 peer-reviewed publications in the areas of clinical microbiology and molecular diagnostics. He has served of the scientific advisory boards and provided consulting services to many start-up and established diagnostic companies. In addition he has experience with FDA clinical trial work and served as a member and consultant to the CDRH FDA Microbiology Devices Panel.

Robin Patel, MD, Professor of Medicine and Microbiology

Robin Patel, MD, Professor of Medicine and Professor of Microbiology, is Director of the Clinical Bacteriology Laboratory and the Infectious Diseases Research Laboratory and Chair of the Division of Clinical Microbiology, Mayo Clinic, USA. Prior to taking a staff position at Mayo in 1996, she completed  residencies in Internal Medicine and Microbiology in Rochester, Minnesota, and a fellowship in Infectious Diseases at the College of Medicine, Mayo Clinic.  Robin Patel’s research focuses on clinical bacteriology diagnostic testing, antimicrobial resistance, and microbial biofilms. She has published over 250 peer-reviewed manuscripts and has delivered numerous national and international presentations. She graduated from Princeton University with a  BA in Chemistry in 1985 and from McGill University in Montreal, Canada, with an MD (C.M.) in 1989.